Bonum Therapeutics
PrivateLast Round
Early Stage
VC
Apr 17, 2026
Total Funding Raised
$93M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Bonum Therapeutics is a biopharmaceutical company that develops conditionally active protein-based drugs designed to sense their local environment and activate in response to provide targeted treatments for cancer and other immune-related disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bonum Therapeutics Comparables
Compare Bonum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Voro Therapeutics | 87% | |
| Amberstone Biosciences | 86% | |
| Soteria Biotherapeutics | 84% | |
Bonum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Apr 17, 2026 | ||||
| Series A | Nov 15, 2022 |
Bonum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series A |
| Codon Capital | Series A |
| Digitalis Ventures | Series A |
| RiverVest Venture Partners | Series A |
| Roche Venture Fund | Series A |
| 3x5 Partners | Series A |
| Vivo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 54% MoM.
- Apr 17, 2026
Raised $27M in an early stage VC round.
Bonum Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bonum Therapeutics's valuation, stock price, and market status.